Unknown

Dataset Information

0

Asymmetric dimethylarginine - a prognostic marker for transplant outcome?

ABSTRACT:

SUBMITTER: Woo J 

PROVIDER: S-EPMC6442947 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Asymmetric dimethylarginine - a prognostic marker for transplant outcome?

Woo Janghee J   Deeg H Joachim HJ  

Haematologica 20190401 4

Similar Datasets

Unknown The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X.
| S-EPMC5716529 | biostudies-literature
Unknown Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.
| S-EPMC5460274 | biostudies-literature
Unknown The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome.
| S-EPMC10276836 | biostudies-literature
Unknown HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
| S-EPMC3360839 | biostudies-literature
Unknown Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway.
| S-EPMC8390558 | biostudies-literature
Unknown L-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study.
| S-EPMC8964544 | biostudies-literature
Unknown Asymmetric Dimethylarginine Disrupts Tumor Antigen Presentation in Breast Cancer.
| S-EPMC12111280 | biostudies-literature
Unknown Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation.
| S-EPMC4899814 | biostudies-literature
Unknown Asymmetric dimethylarginine-induced oxidative damage leads to cerebrovascular dysfunction.
| S-EPMC8328760 | biostudies-literature
Unknown Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation.
| S-EPMC8748781 | biostudies-literature